Dr. Lawrence Karsh On Treatment Sequencing In Metastatic Castration-Resistant Prostate Cancer

Dr. Lawrence Karsh on Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer

Dr. Karsh on the TERRAIN Trial for Prostate Cancer

Treatment sequencing for metastatic castration-resistant prostate cancer

The Challenges for Urologists Treating Metastatic Castrate Resistant Prostate Cancer Patients

Grand Rounds in Urology

Dr. Dorff on Sequencing in Metastatic Castration-Resistant Prostate Cancer

AUA: Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer

Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer

The Benefits and Challenges Present and Future for the Urologist Treating mCRPC

Grand Rounds in Urology

Metastatic Castration Resistant Prostate Cancer (mCRPC) – Inroads in Improved Outcomes

Grand Rounds in Urology

Dr. Shore on Therapy Combination and Sequencing in Castration-Resistant Prostate Cancer

Prostate cancer: treatment sequencing and choice

Treatment sequencing and combinations for prostate cancer

BMI and clinical outcomes in patients with metastatic castration-resistant prostate cancer

Ask the Expert: How Do Urologists and Medical Oncologists Differ in Their Approach to Prostate Cance

Grand Rounds in Urology

Larry Karsh - How do I choose Androgen Biosynthesis Inhibitor, Androgen Receptor Antagonist, or both

Cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer

Treating Non-Metastatic Castrate Resistant Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

Prostate Cancer Research Institute

Updates in the treatment of castration-resistant prostate cancer

Castration Resistant #ProstateCancer | #MarkScholzMD #PCRI

Prostate Cancer Research Institute

Treatment options for patients with metastatic castration-resistant prostate cancer